---
title: "Berry Genomics wins the bid for the central special lottery public welfare fund to support the enhancement of rare disease diagnosis and treatment capabilities project"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/242299332.md"
description: "Beijing Berry Genomics Medical Laboratory, a subsidiary of Berry Genomics, recently won the bid for the rare disease diagnosis and treatment capacity enhancement project (Phase VI) supported by the Central Special Lottery Public Welfare Fund. This is the fifth time the company has won this project"
datetime: "2025-05-29T01:30:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/242299332.md)
  - [en](https://longbridge.com/en/news/242299332.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/242299332.md)
generator: "portal-rs"
---

# Berry Genomics wins the bid for the central special lottery public welfare fund to support the enhancement of rare disease diagnosis and treatment capabilities project

According to Berry Genomics, the announcement of the winning bid for the project to enhance the diagnosis and treatment capabilities for rare diseases, supported by the central special lottery public welfare fund, has been released. Beijing Berry Health Medical Laboratory, a subsidiary of Berry Genomics, won the bid. Previously, the company had won this project four times

### Related Stocks

- [000710.CN](https://longbridge.com/en/quote/000710.CN.md)

## Related News & Research

- [Meta vs. Microsoft: One Hyperscaler Stock Has Room to Grow, the Other Lacks a Catalyst, Says Investor](https://longbridge.com/en/news/300456248.md)
- [What's Going On With Oracle Stock Tuesday?](https://longbridge.com/en/news/300437295.md)
- [AI’s $1 Trillion Funding Problem Is Moving From Stocks to Bonds](https://longbridge.com/en/news/300336501.md)
- [What Is Going on With Marvell Technology Stock on Tuesday?](https://longbridge.com/en/news/300460741.md)
- [Micron or Nvidia: One AI Stock Is Poised to Outperform, the Other Is Harder to Call, Says Goldman Sachs](https://longbridge.com/en/news/300359724.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**